CCI
AEGR

Columbus Circle Investors’s Aegerion Pharmaceuticals AEGR Stock Holding History

Columbus Circle Investors’s Portfolio AEGR Stock Details AEGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-16,642
Closed -$556K – 346
2014
Q3 		$556K Buy
16,642
+1,310
+9% +$40.7K ﹤0.01% 247
2014
Q2 		$492K Sell
15,332
-36,139
-70% -$1.35M ﹤0.01% 270
2014
Q1 		$2.38M Buy
51,471
+12,749
+33% +$748K 0.02% 249
2013
Q4 		$2.75M Sell
38,722
-283,479
-88% -$21.7M 0.02% 258
2013
Q3 		$27.6M Buy
322,201
+7,560
+2% +$641K 0.2% 132
2013
Q2 		$19.9M Buy
+314,641
New +$16.7M 0.16% 151

Other funds holding AEGR

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Columbus Circle Investors's AEGR Position: Q4 2014 in Review

Columbus Circle Investors sold out of Aegerion Pharmaceuticals (AEGR) in Q4 2014, closing a stake of 16,642 shares — an estimated $556K sold.

Columbus Circle Investors first reported a position in AEGR in Q2 2013 and held it in 6 quarters. The position peaked at $27.6M in Q3 2013. 95 funds tracked by Wall St. Rank hold AEGR as of Q4 2014.

  • Columbus Circle Investors reported no remaining Aegerion Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
  • Columbus Circle Investors sold 16,642 Aegerion Pharmaceuticals shares in Q4 2014, an estimated $556K.
  • Columbus Circle Investors first reported a position in Aegerion Pharmaceuticals in Q2 2013 and held it in 6 quarters.
  • Columbus Circle Investors's Aegerion Pharmaceuticals position peaked at $27.6M in Q3 2013.
  • 95 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q4 2014.

Based on Columbus Circle Investors's 13F filing for Q4 2014, filed 5 Feb 2015.